References from Presentation: “HIV & Tobacco Use: A Growing Concern”
by Loretta Worthington, MA, MSP (Rainbow Health Initiative)
In order of discussion:
Palella, F. J., Jr., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., et al. (2006).
Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease
in the HIV Outpatient Study. Journal of Acquired Immune Deficiency
Syndrome, 2006;43(1):27-34
Palella, F. J., Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G.
A., et al. (1998). Declining morbidity and mortality among patients with advanced human
immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of
Medicine, 338(13), 853–860.
Lohse, N., Hansen, A. B., Pedersen, G., Kronborg, G., Gerstoft, J., Sorensen, H. T., et al. (2007).
Survival of persons with and without HIV infection in Denmark, 1995–2005. Annals of
Internal Medicine, 146(2), 87–95.
Patel, N., Talwar, A., Reichert, V. C., Brady, T., Jain, M., & Kaplan, M. H. (2006). Tobacco and HIV.
Clinics in Occupational and Environmental Medicine, 5, 193–207.
Collins, R. L., Kanouse, D. E., Gifford, A. L., Senterfitt, J. W., Schuster, M. A., McCaffrey, D. F., et al.
(2001). Changes in health-promoting behavior following diagnosis with HIV: Prevalence and
correlates in a national probability sample. Health Psychology, 20(5), 351–360.
Burkhalter, J. E., Springer, C. M., Chhabra, R., Ostroff, J. S., & Rapkin, B. D. (2005). Tobacco use
and readiness to quit smoking in low-income HIV-infected persons. Nicotine and Tobacco
Research, 7(4), 511–522.
Miguez-Burbano MJ, Burbano X, Duncand R, Pitchenik A, Quinteroa N, Floresa M, Allan R,
Shor-Posner G. Increased risk of Pneumocystis carinii and community-acquired pneumonia
with tobacco use in HIV disease. International J of Infectious Disease, 2005, 9(4): 208-217.
Diaz PT, King MA, Pacht ER, Wewers MD, Gadek JE, Nagaraja HN, Drake J, & Clanton T L.
Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Annals
of Internal Medicine, 2000, 132: 369–372.
Diaz PT, King MA, Pacht ER, Wewers MD, Gadek JE, Neal D, Nagaraja HN, Drake J, & Clanton T
L. The pathophysiology of pulmonary diffusion impairment in human immunodeficiency virus
infection. American Journal of Respiratory and Critical Care Medicine, 1999, 160: 272–277.
Vidrine DJ Cigarette Smoking and HIV/AIDS: Health Implications, Smoker Characteristics and
Cessation Strategies. AIDS Education and Prevention, 21, Supplement A, 3–13, 2009.
Burns, D. N., Landesman, S., Muenz, L. R., Nugent, R. P., Goedert, J. J., Minkoff, H., Walsh, J. H.,
Mendez, H., Rubinstein, A., & Willoughby, A. (1994). Cigarette smoking, premature rupture of
membranes, and vertical transmission of HIV-1 among women with low CD4+ levels. Journal
of Acquired Immune Deficiency Syndromes, 7, 718–726.
1
References from Presentation: “HIV & Tobacco Use: A Growing Concern”
by Loretta Worthington, MA, MSP (Rainbow Health Initiative)
Conley, L. J., Bush, T. J., Buchbinder, S. P., Penley, K. A., Judson, F. N., & Holmberg, S. D. (1996).
The association between cigarette smoking and selected HIV-related medical conditions. AIDS,
10, 1121–1126.
Flanigan, T. P., Hogan, J. W., Smith, D., Schoenbaum, E., Vlahov, D., Schuman, P., & Mayer, K.
(1999). Self-reported bacterial infections among women with or at risk for human
immunodeficiency virus infection. Clinical Infectious Diseases, 29, 608–612.
Miguez-Burbano et al. 200 Miguez-Burbano MJ, Burbano X, Duncand R, Pitchenik A, Quinteroa
N, Floresa M, Allan R, Shor-Posner G. Increased risk of Pneumocystis carinii and communityacquired pneumonia with tobacco use in HIV disease. International J of Infectious Disease,
2005, 9(4): 208-217.
Sroussi, H., Villines, D., Epstein, J., Alves, M. and Alves, M. (2007), Oral lesions in HIV-positive
dental patients – one more argument for tobacco smoking cessation. Oral Diseases, 13: 324–
328.
Diaz PT, King MA, Pacht ER, Wewers MD, Gadek JE, Nagaraja HN, Drake J, & Clanton T L.
Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Annals
of Internal Medicine, 2000, 132: 369–372.
Diaz PT, King MA, Pacht ER, Wewers MD, Gadek JE, Neal D, Nagaraja HN, Drake J, & Clanton T
L. The pathophysiology of pulmonary diffusion impairment in human immunodeficiency virus
infection. American Journal of Respiratory and Critical Care Medicine, 1999, 160: 272–277.
Miguez-Burbano MJ, Burbano X, Ashkin D, Pitchenik A, Allan R, Pineda L, Rodriguez N, ShorPosner G. Impact of tobacco use on the development of opportunistic respiratory infections in
HIV seropositive patients on antiretroviral therapy. Addict Biol. 2003 Mar;8(1):39-43.
Burkhalter JE, Springer CM, Chhabra R, Ostroff J, Rapkin B. Tobacco use and readiness to quit
smoking in low-income HIV-infected persons. Nicotine & Tobacco Research, 2005, 7(4): 511–
522.
Palefsky, J. M., Minkoff, H., Kalish, L. A., Levine, A., Sacks, H. S., Garcia, P., et al. (1999).
Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)positive and high-risk HIV-negative women. Journal of the National Cancer Institute, 91(3),
226–236.
Brockmeyer, N., Kreuter, A., Pfister, H., Altmeyer, P., & Wieland, U. (2007, February). Elevated
anal HPV16 DNA loads in HIV+ men who smoke [abstract 872]. Paper presented at the 14th
Conference on Retroviruses and Opportunistic Infections.
Monforte, A., Abrams, D., Pradier, C., Weber, R.,Bonnet, F., De Wit, S., et al. (2007, February).
HIV-induced immunodeficiency and risk of fatal AIDS-defining and non-AIDSdefining
Malignancies: Results from the D:A:D Study [abstract 84]. Paper presented at the 14th
Conference on Retroviruses and Opportunistic Infections.
2
References from Presentation: “HIV & Tobacco Use: A Growing Concern”
by Loretta Worthington, MA, MSP (Rainbow Health Initiative)
Vidrine DJ Cigarette Smoking and HIV/AIDS: Health Implications, Smoker Characteristics and
Cessation Strategies. AIDS Education and Prevention, 21, Supplement A, 3–13, 2009.
Palella, F. J., Jr., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., et al. (2006).
Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease
in the HIV Outpatient Study. Journal of Acquired Immune Deficiency
Syndrome, 2006;43(1):27-34
Burns DN et al. (1994). Cigarette smoking, premature rupture of membranes, and vertical
transmission of HIV-1 among women with low CD4+ levels.
Turner BJ; Hauck WW; Fanning TR; Markson LE; Division of General Internal Medicine,
Jefferson Medical College,; Philadelphia, Pennsylvania, USA. “Cigarette smoking and maternalchild HIV transmission”. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Apr 1;14(4):32737. Unique Identifier : AIDSLINE MED/97265568
Friss-Moller N, Weber R, Preiss P, Theibaut R, Kirk O, d'Arminio Monforte A, et al.
Cardiovascular disease risk factors in HIV patients—association with antiretroviral therapy.
Results from the DAD study. AIDS 2003;17(8):1179–1193.
Mooser V. Atherosclerosis and HIV in the highly active antiretroviral therapy era: Towards an
epidemic of cardiovascular disease? AIDS 2003;17(Suppl 1):65–69.
Saves M, Chene G, Ducimetiere P, Leport C, Le Moal G, Amouyel P, et al. Risk factors for
coronary heart disease in patients treated for human immunodeficiency infection compared
with the general population. Clinical Infectious Diseases 2003;37(2):292–298.
Vittecoq D, Escaut L, Chironi G, Teicher E, Monsuez JJ, Andrejak M, et al. Coronary heart
disease in HIV-infected patients in the highly active antiretroviral treatment era. AIDS
2003;17(Suppl 1):70– 76.
Crothers, K., Griffith, T. A., McGinnis, K. A., Rodriguez-Barradas, M. C., Leaf, D. A., Weissman, S.,
et al. (2005). The impact of cigarette smoking on mortality, quality of life, and comorbid
illness among HIV-positive veterans. Journal of General Internal Medicine, 20, 1142–1145.
Miguez-Burbano MJ, Burbano X, Ashkin D, Pitchenik A, Allan R, Pineda L, Rodriguez N, ShorPosner G. Impact of tobacco use on the development of opportunistic respiratory infections in
HIV seropositive patients on antiretroviral therapy. Addict Biol. 2003 Mar;8(1):39-43.
Diaz PT, King MA, Pacht ER, Wewers MD, Gadek JE, Nagaraja HN, Drake J, & Clanton T L.
Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Annals
of Internal Medicine, 2000, 132: 369–372.
Diaz PT, King MA, Pacht ER, Wewers MD, Gadek JE, Neal D, Nagaraja HN, Drake J, & Clanton T
L. The pathophysiology of pulmonary diffusion impairment in human immunodeficiency virus
infection. American Journal of Respiratory and Critical Care Medicine, 1999, 160: 272–277
3
References from Presentation: “HIV & Tobacco Use: A Growing Concern”
by Loretta Worthington, MA, MSP (Rainbow Health Initiative)
Miguez-Burbano MJ, Burbano X, Ashkin D, Pitchenik A, Allan R, Pineda L, Rodriguez N, ShorPosner G. Impact of tobacco use on the development of opportunistic respiratory infections in
HIV seropositive patients on antiretroviral therapy. Addict Biol. 2003 Mar;8(1):39-43.
Lo J, Mulligan K, Tai V, Algren H, Schambelan M. Buffalo hump in men with HIV-1 infection.
Lancet 1998;351:867–70.
Miller K, Jones E, Yanovski J, Shankar R, Feurstein I, Falloon J. Visceral abdominal fat
accumulation associated with use of indinavir. Lancet 1998; 351:871–5.
United States Department of Health and Human Services (DHHS). The health consequences of
smoking: nicotine addiction. Washington, DC: US Government Printing Office, 1998. DHHS
publication no. CDC-88-8406.
Crothers, K., Griffith, T. A., McGinnis, K. A., Rodriguez-Barradas, M. C., Leaf, D. A., Weissman, S.,
et al. (2005). The impact of cigarette smoking on mortality, quality of life, and comorbid illness
among HIV-positive veterans. Journal of General Internal Medicine, 20, 1142–1145.
Reynolds, N.R., Neidig, J.L., & Wewers, M.E. (2004). Illness representation and smoking
behavior: a focus group study of HIVpositive men. J Assoc Nurses AIDS Care, 15(4), 37-47.
Turner, J., Page-Shafer, K., Chin, D. P., Osmond, D., Mossar, M., Markstein, L., et al. (2001).
Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons
with HIV infection. AIDS Patient Care and STDs, 15, 615–624.
Vidrine, D. J., Arduino, R. C., & Gritz, E. R. (2007). The effects of smoking abstinence on
symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care
and STDs, 21(9), 659–666.
Fleishman J, Mor V, Laliberte L. Longitudinal patterns of medical service use and cost among
people with AIDS. Health Serv Res 1995; 30:403–24.
Manley M, Epps RP, Husten C, Glynn T, Shopland D. Clinical interventions in tobacco control. A
National Cancer Institute training program for physicians. JAMA 1991;266:3172–3.
Ockene JK. Physician-delivered interventions for smoking cessation: strategies for increasing
effectiveness. Prev Med 1987; 16:723–37
4